rs62267114

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_000158.4(GBE1):​c.15G>A​(p.Met5Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00151 in 1,604,598 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/23 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0012 ( 1 hom., cov: 34)
Exomes 𝑓: 0.0015 ( 2 hom. )

Consequence

GBE1
NM_000158.4 missense

Scores

1
18

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:7B:3O:1

Conservation

PhyloP100: -0.644
Variant links:
Genes affected
GBE1 (HGNC:4180): (1,4-alpha-glucan branching enzyme 1) The protein encoded by this gene is a glycogen branching enzyme that catalyzes the transfer of alpha-1,4-linked glucosyl units from the outer end of a glycogen chain to an alpha-1,6 position on the same or a neighboring glycogen chain. Branching of the chains is essential to increase the solubility of the glycogen molecule and, consequently, in reducing the osmotic pressure within cells. Highest level of this enzyme are found in liver and muscle. Mutations in this gene are associated with glycogen storage disease IV (also known as Andersen's disease). [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009051472).
BP6
Variant 3-81761503-C-T is Benign according to our data. Variant chr3-81761503-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 441107.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=7, not_provided=1, Likely_benign=2}. Variant chr3-81761503-C-T is described in Lovd as [Likely_benign].
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GBE1NM_000158.4 linkc.15G>A p.Met5Ile missense_variant Exon 1 of 16 ENST00000429644.7 NP_000149.4 Q04446Q59ET0
GBE1XR_007095662.1 linkn.143G>A non_coding_transcript_exon_variant Exon 1 of 15

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GBE1ENST00000429644.7 linkc.15G>A p.Met5Ile missense_variant Exon 1 of 16 1 NM_000158.4 ENSP00000410833.2 Q04446

Frequencies

GnomAD3 genomes
AF:
0.00117
AC:
178
AN:
152142
Hom.:
1
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.000555
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000785
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00203
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.000861
AC:
195
AN:
226356
AF XY:
0.000848
show subpopulations
Gnomad AFR exome
AF:
0.000397
Gnomad AMR exome
AF:
0.000768
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00157
Gnomad OTH exome
AF:
0.000893
GnomAD4 exome
AF:
0.00154
AC:
2243
AN:
1452456
Hom.:
2
Cov.:
33
AF XY:
0.00147
AC XY:
1062
AN XY:
722230
show subpopulations
Gnomad4 AFR exome
AF:
0.000240
AC:
8
AN:
33288
Gnomad4 AMR exome
AF:
0.000692
AC:
30
AN:
43336
Gnomad4 ASJ exome
AF:
0.0000385
AC:
1
AN:
25980
Gnomad4 EAS exome
AF:
0.00
AC:
0
AN:
39062
Gnomad4 SAS exome
AF:
0.000128
AC:
11
AN:
85724
Gnomad4 FIN exome
AF:
0.00
AC:
0
AN:
50872
Gnomad4 NFE exome
AF:
0.00192
AC:
2126
AN:
1108984
Gnomad4 Remaining exome
AF:
0.00107
AC:
64
AN:
59898
Heterozygous variant carriers
0
128
257
385
514
642
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
86
172
258
344
430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00117
AC:
178
AN:
152142
Hom.:
1
Cov.:
34
AF XY:
0.00112
AC XY:
83
AN XY:
74320
show subpopulations
Gnomad4 AFR
AF:
0.000555
AC:
0.000554993
AN:
0.000554993
Gnomad4 AMR
AF:
0.000785
AC:
0.000785032
AN:
0.000785032
Gnomad4 ASJ
AF:
0.00
AC:
0
AN:
0
Gnomad4 EAS
AF:
0.00
AC:
0
AN:
0
Gnomad4 SAS
AF:
0.00
AC:
0
AN:
0
Gnomad4 FIN
AF:
0.00
AC:
0
AN:
0
Gnomad4 NFE
AF:
0.00203
AC:
0.00202852
AN:
0.00202852
Gnomad4 OTH
AF:
0.00239
AC:
0.00238777
AN:
0.00238777
Heterozygous variant carriers
0
10
20
29
39
49
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00161
Hom.:
0
Bravo
AF:
0.000997
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00147
AC:
12
ExAC
AF:
0.000704
AC:
83

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:7Benign:3Other:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:3
Aug 02, 2022
Mayo Clinic Laboratories, Mayo Clinic
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

BP4 -

Aug 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 12, 2025
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Identified in a family with familial primary hyperparathyroidism in published literature (PMID: 27745835); In silico analysis suggests that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 27745835) -

Glycogen storage disease, type IV;C1849722:Adult polyglucosan body disease Uncertain:2
Oct 15, 2023
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:research

- -

Oct 31, 2018
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Glycogen storage disease, type IV Uncertain:1Other:1
-
GenomeConnect, ClinGen
Significance:not provided
Review Status:no classification provided
Collection Method:phenotyping only

GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. -

Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -

Adult polyglucosan body disease Uncertain:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -

not specified Benign:1
Oct 03, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: GBE1 c.15G>A (p.Met5Ile) results in a conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00093 in 257704 control chromosomes, predominantly at a frequency of 0.0017 within the Non-Finnish European subpopulation in the gnomAD database, including 1 homozygote. To our knowledge, no occurrence of c.15G>A in individuals affected with GBE1-Related Disorders and no experimental evidence demonstrating its impact on protein function have been reported. Six submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as likely benign. -

GBE1-related disorder Benign:1
Jan 31, 2022
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Glycogen storage disease, type IV;C1856301:Glycogen storage disease IV, classic hepatic Benign:1
Jan 15, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.65
T
BayesDel_noAF
Benign
-0.72
CADD
Benign
6.0
DANN
Benign
0.93
DEOGEN2
Benign
0.080
T
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.0091
N
LIST_S2
Benign
0.31
T
M_CAP
Benign
0.0035
T
MetaRNN
Benign
0.0091
T
MetaSVM
Benign
-0.97
T
MutationAssessor
Benign
0.0
N
PrimateAI
Uncertain
0.67
T
PROVEAN
Benign
-0.060
N
REVEL
Benign
0.024
Sift
Benign
0.55
T
Sift4G
Benign
0.23
T
Polyphen
0.0
B
Vest4
0.12
MutPred
0.36
Gain of catalytic residue at M5 (P = 0.0053);
MVP
0.20
MPC
0.032
ClinPred
0.0026
T
GERP RS
1.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.31
gMVP
0.48
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs62267114; hg19: chr3-81810654; API